AlphaYouMZ
Insider buying
Mahkam Zanganeh bought $50M of Summit Therapeutics Inc. (SMMT) stock
Mahkam Zanganeh, Co-Chief Executive Officer, 10% of Summit Therapeutics Inc. (SMMT), bought 3,810,000 shares of SMMT stock worth $50M, per an SEC Form 4 filed Jun 12, 2026.
It was an open-market purchase.
The trade was reported on Jun 12, 2026.
SMMT has moved +20.6% since the trade date, from $14.01 to $16.90 (Sep 21, 2026 close).
- Traded
- Jun 12, 2026
- Disclosed
- Jun 12, 2026
- Filing delay
- 0 days
- Price since
- +20.6%
- Role
- Co-Chief Executive Officer, 10%
- Source
- SEC Form 4
More SMMT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.